Adult polyglucosan body disease (APBD) is characterized by the accumulation of insoluble glucose polymers within the central and peripheral nervous systems. A common missense mutation in the glycogen branching enzyme (GBE1) gene has been identified in Ashkenazi patients with APBD. We report on a non-Jewish patient with APBD on whom we performed proton magnetic resonance spectroscopic imaging of the brain. GBE activity in fibroblasts was markedly reduced, and a novel heterozygous mutation was identified in the GBE1 gene. Our findings widen the spectrum of APBD genotypes, underline the importance of performing GBE analysis in all APBD patients, and suggest that brain white matter degeneration in APBD may result from tissue damage involving ax...
Background: Glycogen storage disease type IV (GSD IV), caused by GBE1 mutations, has a quite wide ph...
Adult polyglucosan body disease (APBD) is a rare neurological disease, characterized by adult onset ...
Background: A 49-year-old male presented with late-onset demyelinating peripheral neuropathy, cerebe...
Adult polyglucosan body disease (APBD) is characterized by the accumulation of insoluble glucose pol...
We report the clinical, neuro-imaging, pathological and biochemical features of an Italian family in...
Adult polyglucosan body disease (APBD) is a metabolic disorder usually caused by glycogen branching ...
We report the clinical, neuro-imaging, pathological and biochemical features of an Italian family in...
A dult polyglucosan body disease (APBD) is character-ized after 50 years of age by the onset of prog...
Objective: Adult polyglucosan body disease (APBD) is an autosomal recessive leukodystrophy character...
Adult polyglucosan body disease is a rare autosomal recessive disease, caused by glycogen branching ...
Adult Polyglucosan Body Disease (APBD) is a rare inherited leukodystrophy associated with axonal pol...
Inadequate glycogen branching enzyme 1 (GBE1) activity results in different forms of glycogen storag...
Adult polyglucosan body disease (APBD) is caused by bi-allelic pathogenic variants in GBE1 and typic...
Adult polyglucosan body disease (APBD) is a neurological, adult-onset variant of glycogen storage di...
Adult polyglucosan body disease (APBD) is characterized by the development of progressive gait dysfu...
Background: Glycogen storage disease type IV (GSD IV), caused by GBE1 mutations, has a quite wide ph...
Adult polyglucosan body disease (APBD) is a rare neurological disease, characterized by adult onset ...
Background: A 49-year-old male presented with late-onset demyelinating peripheral neuropathy, cerebe...
Adult polyglucosan body disease (APBD) is characterized by the accumulation of insoluble glucose pol...
We report the clinical, neuro-imaging, pathological and biochemical features of an Italian family in...
Adult polyglucosan body disease (APBD) is a metabolic disorder usually caused by glycogen branching ...
We report the clinical, neuro-imaging, pathological and biochemical features of an Italian family in...
A dult polyglucosan body disease (APBD) is character-ized after 50 years of age by the onset of prog...
Objective: Adult polyglucosan body disease (APBD) is an autosomal recessive leukodystrophy character...
Adult polyglucosan body disease is a rare autosomal recessive disease, caused by glycogen branching ...
Adult Polyglucosan Body Disease (APBD) is a rare inherited leukodystrophy associated with axonal pol...
Inadequate glycogen branching enzyme 1 (GBE1) activity results in different forms of glycogen storag...
Adult polyglucosan body disease (APBD) is caused by bi-allelic pathogenic variants in GBE1 and typic...
Adult polyglucosan body disease (APBD) is a neurological, adult-onset variant of glycogen storage di...
Adult polyglucosan body disease (APBD) is characterized by the development of progressive gait dysfu...
Background: Glycogen storage disease type IV (GSD IV), caused by GBE1 mutations, has a quite wide ph...
Adult polyglucosan body disease (APBD) is a rare neurological disease, characterized by adult onset ...
Background: A 49-year-old male presented with late-onset demyelinating peripheral neuropathy, cerebe...